Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Muscular Atrophy × 1 year × Clear all

Phase

Phase NA 3 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 30 Carcinoma, Non-Small-Cell Lung 23 Neoplasm Metastasis 18 Colorectal Neoplasms 14 Breast Neoplasms 14 Prostatic Neoplasms 13 Carcinoma, Hepatocellular 12 Squamous Cell Carcinoma of Head and Neck 11 Stomach Neoplasms 9 Recurrence 9 Lung Neoplasms 9 Ovarian Neoplasms 8 Myasthenia Gravis 8 Melanoma 8 Leukemia, Myeloid, Acute 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Pancreatic Neoplasms 7 Rectal Neoplasms 6 Multiple Myeloma 6 Leukemia 6 Glioblastoma 6 Fatigue 6 Urinary Bladder Neoplasms 5 Mouth Neoplasms 5 Lymphoma 5 Laryngeal Neoplasms 5 Hematologic Neoplasms 5 Fallopian Tube Neoplasms 5 Colonic Neoplasms 5 Cholangiocarcinoma 5

Interventions

Standard of Care 1 Olanzapine 1 Enteral Nutrition 1 Cyproheptadine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06175273 2025-09-18

POINT

University of Kentucky

Phase 2/3 Completed

Muscular Atrophy, Neoplasms, Child Nutrition Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡